School of Medicine


Showing 1-50 of 176 Results

  • Kimberly Allison

    Kimberly Allison

    Professor of Pathology

    Current Research and Scholarly InterestsDr. Allison’s clinical expertise is in breast pathology. Her research interests include how standards should be applied to breast cancer diagnostics (such as ER and HER2 testing), the utility of molecular panel-based testing in breast cancer, digital pathology applications and identifying the most appropriate management of specific pathologic diagnoses.

  • Michael Angelo

    Michael Angelo

    Associate Professor of Pathology
    On Leave from 07/15/2025 To 02/11/2026

    BioMichael Angelo, MD PhD is a board-certified pathologist and assistant professor in the department of Pathology at Stanford University School of Medicine. Dr. Angelo is a leader in high dimensional imaging with expertise in tissue homeostasis, tumor immunology, and infectious disease. His lab has pioneered the construction and development of Multiplexed Ion Beam Imaging by time of flight (MIBI-TOF). MIBI-TOF uses secondary ion mass spectrometry and metal-tagged antibodies to achieve rapid, simultaneous imaging of dozens of proteins at subcellular resolution. In recognition of this achievement, Dr. Angelo received the NIH Director’s Early Independence award in 2014. His lab has since used this novel technology to discover previously unknown rule sets governing the spatial organization and cellular composition of immune, stromal, and tumor cells within the tumor microenvironment in triple negative breast cancer. These findings were found to be predictive of single cell expression of several immunotherapy drug targets and of 10-year overall survival. This effort has led to ongoing work aimed at elucidating structural mechanisms in the TME that promote recruitment of cancer associated fibroblasts, tumor associated macrophages, and extracellular matrix remodeling. Dr. Angelo is the recipient of the 2020 DOD Era of Hope Award and a principal investigator on multiple extramural awards from the National Cancer Institute, Breast Cancer Research Foundation, Parker Institute for Cancer Immunotherapy, the Bill and Melinda Gates Foundation, and the Human Biomolecular Atlas (HuBMAP) initiative.

  • Euan A. Ashley

    Euan A. Ashley

    Roger and Joelle Burnell Professor of Genomics and Precision Health, Arthur L. Bloomfield Professor of Medicine and Professor of Genetics, of Biomedical Data Science and, by courtesy, of Pathology

    Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.

  • Jeffrey Axelrod

    Jeffrey Axelrod

    Professor of Pathology

    Current Research and Scholarly InterestsGenetic and cell biological analyses of signals controlling cell polarity and morphogenesis. Frizzled signaling and cytoskeletal organization.

  • Niaz Banaei

    Niaz Banaei

    Professor of Pathology and of Medicine (Infectious Diseases)

    Current Research and Scholarly InterestsHis research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.

  • Ellen Jo Baron

    Ellen Jo Baron

    Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly InterestsNo current scientific activities. I am retired.

  • Dr. Gregory Bean

    Dr. Gregory Bean

    Associate Professor of Pathology

    BioDr. Bean is an Associate Professor who specializes in breast pathology. His research interests include molecular characterization of breast cancer subtypes and precursors. He is also involved with the training of residents and fellows on the breast service.

  • Sean Bendall

    Sean Bendall

    Associate Professor of Pathology

    Current Research and Scholarly InterestsOur goal is to understand the mechanisms regulating the development of human systems. Drawing on both pluripotent stem cell biology, hematopoiesis, and immunology, combined with novel high-content single-cell analysis (CyTOF – Mass Cytometry) and imagining (MIBI-Multiplexed Ion Beam Imaging) we are creating templates of ‘normal’ human cellular behavior to both discover novel regulatory events and cell populations as well as understand dysfunctional processes such as cancer.

  • Gerald Berry

    Gerald Berry

    Richard Kempson, M.D., Professor of Surgical Pathology

    Current Research and Scholarly InterestsCardiopulmonary and pulmonary transplant medicine; diagnostic surgical pathology

  • David Bingham

    David Bingham

    Clinical Assistant Professor, Pathology

    BioDavid Bingham MD is a clinical assistant pathologist specializing in gastrointestinal pathology. He is from Connecticut, graduated from Yale with a BA, and went to Columbia P&S for medical school. He did a residency in Pathology at Stanford University, graduated in 1992 and has been here ever since as a faculty member.

  • Matthew Bogyo

    Matthew Bogyo

    Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsOur lab uses chemical, biochemical, and cell biological methods to study protease function in human disease. Projects include:

    1) Design and synthesis of novel chemical probes for serine and cysteine hydrolases.

    2) Understanding the role of hydrolases in bacterial pathogenesis and the human parasites, Plasmodium falciparum and Toxoplasma gondii.

    3) Defining the specific functional roles of proteases during the process of tumorogenesis.

    4) In vivo imaging of protease activity

  • Donald E. Born

    Donald E. Born

    Clinical Professor, Pathology

    BioDr. Born obtained his medical degree from the University of Virginia where he also completed a Ph.D. in Neuroscience. His next training occurred at the University of Washington as an Anatomic Pathology resident and Neuropathology fellow. He moved to Stanford in 2013 and as Clinical Professor of Pathology he sees a wide range of samples related to the field of neuropathology.

  • Raffick A.R. Bowen

    Raffick A.R. Bowen

    Clinical Professor, Pathology

    Current Research and Scholarly InterestsMy current research involves the investigation of immunoassay interferences from blood collection tube additives; particularly, silicone surfactants.

  • Scott D. Boyd, MD PhD

    Scott D. Boyd, MD PhD

    Stanford Professor of Food Allergy and Immunology and Professor of Pathology
    On Partial Leave from 08/01/2025 To 01/31/2026

    Current Research and Scholarly InterestsOur goal is to understand the lymphocyte genotype-phenotype relationships in healthy human immunity and in immunological diseases. We apply new technologies and data analysis approaches to this challenge, particularly high-throughput DNA sequencing and single-cell monoclonal antibody generation, in parallel with other functional assays.

  • Ryanne Ashley Brown, MD, MBA

    Ryanne Ashley Brown, MD, MBA

    Clinical Associate Professor, Pathology
    Clinical Associate Professor (By courtesy), Dermatology

    BioRyanne Brown, M.D., M.B.A., is a Clinical Assistant Professor of Pathology and (by courtesy) Dermatology. She completed her residency training in Anatomic and Clinical Pathology followed by Surgical Pathology and Dermatopathology fellowships at Stanford. She is board certified in both Anatomic Pathology and Clinical Pathology (American Board of Pathology) and Dermatopathology (American Boards of Pathology/Dermatology). Her interests include cutaneous lymphoma and histiocytic neoplasms.

  • Lawrence Walden Browne ("Walden")

    Lawrence Walden Browne ("Walden")

    Clinical Assistant Professor, Pathology

    BioI am an Anatomic and Clinical Pathologist with sub-specialty Fellowship training in Liver and Gastrointestinal Pathology. Prior to my career in medicine I earned a doctorate from Stanford University in Spanish and Comparative Literature.

  • Eugene Butcher

    Eugene Butcher

    Klaus Bensch Professor of Pathology
    On Partial Leave from 09/15/2025 To 12/19/2025

    Current Research and Scholarly InterestsOur interests include:
    -Lymphocyte migration and vascular specialization in immunity and inflammation;
    -Single-cell and multi-omics dissection of vascular and immune system heterogeneity;
    -AI-driven deorphanization of GPCRs and ligand discovery
    -Reprogramming of vascular and immune niches in immunity and tolerance;
    -Systems biology of immune cell targeting in health and disease

  • Emily Chan

    Emily Chan

    Associate Professor of Pathology (Clinical Pathology)

    BioDr. Chan is an Associate Professor of Pathology at Stanford University. She completed her MD, PhD at New York University and Anatomic Pathology residency with subspecialty Genitourinary Pathology training at University of California-San Francisco (UCSF). She is AP board-certified. Dr. Chan was a GU attending at UCSF for five years before joining Stanford to lead the Genitourinary Pathology Service and Fellowship. She has successfully mentored numerous trainees in projects, publications, and career planning. Dr. Chan has co-authored more than 70 peer-reviewed research publications and has a particular interest in integrating molecular testing in diagnostic pathology, as well as recognition of prostate cancer architectural patterns than can help with prognosis and treatment decision making.

  • Howard Y. Chang, MD, PhD

    Howard Y. Chang, MD, PhD

    Virginia and D. K. Ludwig Professor of Cancer Research, Professor of Genetics and, by courtesy, of Pathology
    On Leave from 12/16/2024 To 12/15/2026

    Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.

  • Vivek Charu

    Vivek Charu

    Assistant Professor of Pathology and of Medicine (Quantitative Sciences)

    BioI am a physician and a biostatistician. My clinical expertise is in the diagnosis of non-neoplastic kidney and liver disease (including transplantation). My research interests center on the design of observational studies and clinical trials, the analysis of observational data, and causal inference.

  • Greg Charville, MD, PhD

    Greg Charville, MD, PhD

    Associate Professor of Pathology

    BioDr. Charville has a special interest in the diagnosis of rare tumors that derive from bone and soft tissues, including muscle, fat, blood vessels, cartilage, and other connective tissues. He also specializes in the classification and study of diseases related to the gastrointestinal and hepatopancreatobiliary systems.

    Dr. Charville particularly enjoys working alongside Stanford's excellent physicians-in-training to classify the most diagnostically challenging cases in collaboration with pathologists from around the world, bringing to bear cutting-edge techniques for comprehensive histologic and molecular characterization in each case. This experience serves as the inspiration for laboratory-based investigation of the molecular underpinnings of human disease, focusing on genetic and epigenetic mechanisms of neoplasia and the translation of these mechanistic insights into novel diagnostic and predictive biomarkers.

  • Michael Cleary

    Michael Cleary

    Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology, Emeritus

    Current Research and Scholarly InterestsThe role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.

  • Maria Inmaculada Cobos Sillero

    Maria Inmaculada Cobos Sillero

    Associate Professor of Pathology

    Current Research and Scholarly InterestsOur lab uses cellular and molecular methods, single-cell technology, and quantitative histology to study human neurodegenerative diseases. Current projects include:

    - Using single-cell RNA-sequencing to understand selective vulnerability and disease progression in human Alzheimer’s disease brain

    - Investigating mechanisms of tau-related neurodegeneration in human brain

    - Studying the neocortical and limbic systems in Diffuse Lewy Body Disease (DLBD) at the single cell level

  • Le Cong

    Le Cong

    Assistant Professor of Pathology (Pathology Research) and of Genetics

    Current Research and Scholarly InterestsOur lab develops gene-editing technologies like novel CRISPR systems and large gene insertion techniques for gene&cell therapy. We also leverages these gene-editing tools for single-cell functional screening, to probe molecular mechanisms of cancer and immunological diseases. To accelerate our work, we integrate AI and machine learning to design and evolve gene-editing proteins/RNAs in silico, pushing the frontier that bridges computational and experimental biology.

  • Joanne Cornbleet

    Joanne Cornbleet

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly InterestsAs medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.

  • Tina Cowan

    Tina Cowan

    Professor of Pathology (Clinical) and, by courtesy, of Pediatrics (Genetics)

    Current Research and Scholarly Interestsscreening and diagnosis of patients with inborn errors of metabolism, including newborn screening, development of new testing methods and genotype/phenotype correlations.

  • Gerald Crabtree

    Gerald Crabtree

    David Korn, MD, Professor of Pathology and Professor of Developmental Biology

    Current Research and Scholarly InterestsChromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin and epigenetic regulation in living cells.

  • John W. Day, MD, PhD

    John W. Day, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology

    Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

  • Dylan Dodd

    Dylan Dodd

    Assistant Professor of Pathology and of Microbiology and Immunology

    Current Research and Scholarly InterestsHarnessing the gut microbiome to treat human disease.

  • Fei Dong

    Fei Dong

    Associate Professor of Pathology

    BioDr. Dong is the Director of Molecular Pathology at Stanford Health Care. The Molecular Pathology laboratory offers a broad menu of clinical diagnostic tests ranging from PCR to next generation sequencing. Dr. Dong's academic interests include the clinical implementation of laboratory developed tests, the development of novel informatics algorithms, and characterization of disease by molecular methods. Before arriving at Stanford, Dr. Dong was on faculty at Brigham and Women’s Hospital/Harvard Medical School for nine years, where he established a track record in education and mentorship and was the recipient of both the Anatomic Pathology and Clinical Pathology resident teaching awards. Dr. Dong has served on committees for the Association for Molecular Pathology, the Clinical and Laboratory Standards Institute, and the United States and Canadian Academy of Pathology. He serves on the editorial boards of multiple scientific journals and is an Associate Editor for the Journal of Molecular Diagnostics.

  • Alex Maurice Dussaq

    Alex Maurice Dussaq

    Clinical Assistant Professor, Pathology

    BioAlex Maurice Dussaq, M.D., Ph.D., is an assistant professor of breast pathology and an associate director of pathology informatics. Dr. Dussaq holds a B.S. in Mathematics and Biochemistry from University of Nevada, Reno and an M.D./Ph.D. from University at Alabama, Birmingham. His Ph.D. focused on novel platform informatics and statistical analysis. He completed a Pathology residency and fellowships at Stanford in breast pathology and clinical informatics. Dr. Dussaq's research interests include the implementation and creation of workflow tools for surgical pathology and lab. He is particularly interested in whole slide image management systems and the future applications of artificial intelligence and large language models in pathology and medicine..

  • Lawrence Eng

    Lawrence Eng

    Professor (Research) of Pathology, Emeritus

    Current Research and Scholarly InterestsAstrocytes make up a substantial proportion of the central nervous system (CNS) and participate in a variety of important physiologic and pathologic processes. They are characterized by vigorous response to diverse neurologic insults.

  • Edgar Engleman

    Edgar Engleman

    Professor of Pathology and of Medicine (Immunology and Rheumatology)
    On Leave from 07/01/2025 To 06/30/2026

    Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

  • Dean W. Felsher

    Dean W. Felsher

    Professor of Medicine (Oncology) and of Pathology

    Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.

  • Marcelo Fernandez Vina

    Marcelo Fernandez Vina

    Professor of Pathology

    BioMarcelo Fernández-Viña, Ph.D., D (ABHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He earned a degree in Biochemistry from the School of Basic Sciences in Rosario, Argentina, and his Ph.D. in Internal Medicine from the University of Buenos Aires Medical School in Argentina. Previously he held a position as a Professor in the Department of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. He has more than 180 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases and in the impact of HLA mismatches in allogeneic transplantation; and 59 book chapters. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR; He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT).He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and Past President of the International HLA & Immunogenetics Workshop.

  • Sebastian Fernandez-Pol

    Sebastian Fernandez-Pol

    Clinical Associate Professor, Pathology

    BioDr. Sebastian Fernandez-Pol is an academic hematopathologist with fellowship training in hematopathology and dermatopathology. He has a particular interest in improving diagnostic accuracy for cutaneous lymphoproliferative disorders. Dr. Fernandez-Pol received his B.A. in chemistry with a concentration in biochemistry from the Washington University in St. Louis in 2003, his MD and PhD from Northwestern University in 2013, and completed his anatomic pathology and clinical pathology residency, hematopathology fellowship, and dermatopathology fellowship at Stanford University in 2019.

  • Andrew Fire

    Andrew Fire

    George D. Smith Professor of Molecular and Genetic Medicine and Professor of Pathology and of Genetics

    Current Research and Scholarly InterestsWhile chromosomal inheritance provides cells with one means for keeping and transmitting genetic information, numerous other mechanisms have (and remain to be) discovered. We study novel cellular mechanisms that enforce genetic constancy and permit genetic change. Underlying our studies are questions of the diversity of inheritance mechanisms, how cells distinguish such mechanisms as "wanted" versus "unwanted", and of the consequences and applications of such mechanisms in health and disease.

  • Ann Folkins

    Ann Folkins

    Associate Professor of Pathology

    Current Research and Scholarly InterestsDr. Folkins' interest is in gynecologic and obstetric pathology, specifically in ovarian and endometrial malignancies and placental clinical-pathologic disorders.

  • Steven Foung

    Steven Foung

    Professor of Pathology

    Current Research and Scholarly InterestsOur research focus is define correlates of protection against hepatitis C virus and other viral pathogens. Detailed characterization of broadly neutralizing human or nonhuman primate monoclonal antibodies against these agents will create high-resolution, functional maps of linear and nonlinear epitopes comprising the major binding sites of both isolate-specific and broadly neutralizing antibodies for rational vaccine design.

  • Lisa Aviva Friedman

    Lisa Aviva Friedman

    Clinical Instructor, Pathology

    BioLisa Friedman completed hematopathology and renal pathology fellowships at Stanford University following residency training at the University of Virginia. She is board certified in hematopathology, anatomic pathology, and clinical pathology. She has an interest in patient care, medical education, and interdisciplinary collaboration.